Erbitux Less Effective For Colon Cancer Patients With Second Gene Mutation

Treatment with cetuximab (Erbitux) was less effective for patients with advanced colorectal cancer...

» read full story

October 23rd, 2008 - 14:46

New Data Triggers Revision of Erbitrux vs. Avastin Study

While the European Medicines Agency, based in London, has approved the use of Erbitux, produced by...

» read full story

June 04th, 2008 - 22:37

Erbitux Boosts Survival in Lung Cancer Patients

Results of a long awaited clinical trial of ImClone Systems Inc's Erbitux, called Flex, give hopes...

» read full story

June 01st, 2008 - 08:50

EU Backs Merck KGaA’s Erbitux for First-Line Use

Germany’s Merck KGaA announced Friday that Erbitux, which it licensed from ImClone System Inc and...

» read full story

May 31st, 2008 - 08:20

Supreme Court Rejects Appeal Seeking Experimental Drug Access

The U.S. Supreme Court announced Monday that it turned away an appeal that sought to give...

» read full story

January 15th, 2008 - 12:01

Cancer Treatment Connected To Gene Make-Up

Recently, scientists have discovered another gene mutation, which makes bowel cancer patients...

» read full story

October 23rd, 2008 - 20:10

EU Backs Erbitux as First Line Drug Against Cancer

The European Medicines Agency, based in London, has approved the use of Erbitux, produced by Merck...

» read full story

June 02nd, 2008 - 11:07